Why Investors Are Exiting Keurig Dr Pepper (KDP) – An Analysis

Keurig Dr Pepper stock is trading -17.62% below its average target price of $35.16 after dropping -1.1% during today's afternoon session. Analysts are giving the Large-Cap Beverages company an average rating of buy and target prices ranging from $27.0 to $41.0 per share.

Keurig Dr Pepper's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.5%. The stock's short ratio is 1.33. The company's insiders own 28.34% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 67.8%. In conclusion, we believe there is positive market sentiment regarding Keurig Dr Pepper.

Institutions Invested in Keurig Dr Pepper

Date Reported Holder Percentage Shares Value
2023-12-31 Capital World Investors 8% 108,032,566 $3,129,163,290
2023-12-31 Vanguard Group Inc 6% 83,014,973 $2,404,528,705
2023-12-31 Blackrock Inc. 6% 80,688,417 $2,337,140,010
2023-12-31 FMR, LLC 5% 64,384,970 $1,864,910,665
2023-12-31 Capital International Investors 4% 56,060,464 $1,623,791,348
2023-12-31 State Street Corporation 3% 43,271,010 $1,253,344,811
2023-12-31 Wellington Management Group, LLP 3% 41,850,944 $1,212,212,599
2023-12-31 Geode Capital Management, LLC 1% 20,171,821 $584,276,798
2023-12-31 Invesco Ltd. 1% 17,437,785 $505,085,445
2023-12-31 JP Morgan Chase & Company 1% 16,254,516 $470,812,058
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.